Nitric oxide synthase (NOS) catalyzes the oxidation of L-arginine to c
itrulline and nitric oxide. C415H and C415A mutants of the neuronal is
oform of NOS (nNOS) were expressed in a baculovirus system and purifie
d to homogeneity for spectral analysis and activity measurements, UV-v
isible spectra of each mutant lacked an observable Soret peak, suggest
ing that neither mutant contained heme. When reduced in the presence o
f CO, however, a small Soret centered at 417 nm could be detected for
the C415H mutant, further supporting the assignment of C415 as the axi
al ligand to the heme. In addition to a deficiency in bound heme, neit
her mutant had any detectable bound tetrahydrobiopterin, as compared t
o wild-type enzyme, which had a ratio of 0.84 mol of bound pteridine:
1 mol of nNOS 160 kDa subunit, The C415H mutant contained bound FAD an
d FMN at levels of 1.0 +/- 0.1 and 0.9 +/- 0.1 mol/mol of nNOS subunit
, respectively. UV-visible spectra of both nNOS mutants retained the d
istinctive absorbance due to tightly associated oxidized flavin prosth
etic groups. Further, the spectra suggested the presence of a neutral
flavin semiquinone, Ferricyanide oxidation of the C415A mutant yielded
a spectrum that was essentially that of oxidized flavin. Ferricyanide
titration showed that the C415A mutant contained approximately 1 redu
cing equiv. Circular dichroism spectra suggested that each mutant was
folded properly, in that both spectra were found to be essentially ide
ntical to the spectrum of wild-type nNOS. Neither mutant could synthes
ize nitric oxide, and neither mutant had the ability to oxidize NADPH
unless an exogenous electron acceptor was added. The rate of cytochrom
e c reduction by each mutant was found to be slightly less, but very s
imilar to the rate (similar to 20 mu mol mg(-1) min(-1)) observed with
wild-type nNOS. In all cases, the rate of cytochrome c reduction incr
eased approximately 15-fold with the addition of calmodulin. Overall,
these spectral and activity data suggest that C415 is the axial heme l
igand and that a point mutation at C415 prevents binding of heme and t
etrahydrobiopterin without interfering with the global folding or the
reductase function of nNOS.